In 26 cases (45%), section 62 was used for the complete treatment plan pending DICO. In 11 cases (19%), it was used to change medications according to a previously approved treatment plan. In three cases (5%) there were cases where section 62 had to be used to add drugs that had been mistakenly missed by DICO on a T3 form. Once (2%) it was used to exceed the maximum allowable dose of a certified drug. In six cases (10%), it was used to administer ECT. In six other cases (10%), it was needed for urgent new drugs (rapid appeasement). In four cases (7%), it had to be used when patients treated on a T2 form withdrew their consent. A SOAD is an independent psychiatrist seconded by the National Agency (Commission Qualité des Soins, CQC) responsible for the SOAD service at the request of the clinician in charge. This doctor will interview the patient, a nurse and another professional before deciding which medications (or ECTs) can be given to the patient.
Medications that can be legally prescribed to the patient should be described on the appropriate formulary, either T2 or T3 for inpatients in prison or CTO11 for patients receiving a CTO. If “urgent treatment” is required, it may be approved by any licensed physician (§§ 62, 64B and 64G) according to certain additional criteria. The Mental Health Act Code of Conduct states that “urgent treatment” only applies if the treatment in question is directly necessary to: The study was conducted retrospectively over a period of 1 year, from January 2009 to December 2009. A list of patients detained during the study period under sections 62 and 64B was requested electronically from the Department of Information Technology. Complete lists of patients for whom T2 or T3 forms were completed and patients who started CTO therapy were also obtained electronically. Section 64 and CTO11 forms were obtained from the Trust`s Mental Health Act Office. Subsequently, relevant case notes were found and more detailed information on the circumstances of the application of Articles 62 and 64B/G was obtained. The Mental Health Act 1983 for England and Wales established the legal framework for the medical treatment of mental disorders for incarcerated patients. One of the protections required by law for patients is that after 3 months have passed since the person first received medication for mental disorders as a detained patient, the medication can only be administered if the treatment is approved either by the physician responsible for the patient`s care (if the patient agrees), or by an independent doctor. who is called a second opinion physician (DICO) when the patient is incapacitated or refuses.
The date from which this 3-month rule applies is called the date of consent to processing (CTT). At the time of this study, for patients on a community treatment order (CTA), all drugs had to be approved by DICO and the time frame was 28 days. For electroconvulsive therapy (ECT), permits were required from the outset of detention. The reasons documented on the urgent processing form, which indicate the need to apply the respective provisions, are summarized below. 3. For the purposes of this Section, treatment shall be irreversible if it has irreversible physical or psychological consequences and dangerous if it involves significant physical danger. In 26 cases (45%), section 62 was invoked due to a delayed DIOS assessment. On 18 occasions (31%), it was used to prevent a serious deterioration of the patient`s condition, 9 times (15%) to prevent the patient from acting violently, twice (3%) to save the patient`s life and once (2%) to relieve the patient`s severe suffering. One form did not document the reason for use.
The details were not taken from another form because the case notes were not found. “centre” means a hospital or other hospital facility for the care and treatment of persons with mental illness or disorder; Treatment otherwise restricted by section 57 or 58 may be granted to a patient detained without consent or second opinion: [(1A) Section 58A, to the extent it relates to electroconvulsive therapy in accordance with subsection (1)(a) of this section, does not apply to treatment referred to in subsection (a) or (b) of subsection (1). “regulations” means the provisions of section 66. It is questionable whether administering a comprehensive treatment plan pending DICO approval meets the spirit or letter of the Mental Health Act`s emergency treatment criteria. The evidence suggests that the legislative protections regarding drugs and potentially CTAs due to the unavailability of DICO are circumvented by the application of the “urgent treatment” provisions. Despite the decrease in DICO applications reported by CQC in 2009-2010, 5 practicing clinicians and DICO undoubtedly believe that CQC`s workload related to DICO investigations has increased significantly since the introduction of CTO. This raises two distinct but interrelated issues. First, has DICO availability decreased as the total number of DIOS requests decreases? If so, why and what can be done about it? This is beyond the scope of this paper. Second, can the need for DICO be reduced without significantly compromising safety precautions? At the time of this study, all patients prescribed medication for mental disorders under a CTO required a DIOS certificate, while incarcerated patients only required a DIOS certificate if they refused treatment or were unable to consent. The CQC stated that patients` consent to a CTO accounted for approximately 45% of DICO requests they received regarding CTO. 5 It seems strange to have greater protection for patients with CTO than for those incarcerated in hospital.
This anomaly has now been corrected so that patients who are capacitive on a CTO no longer need a SOAD certificate. (2) Section 60 and section 61(3) shall not prevent the continuation of treatment or treatment under a plan until compliance with section 57[, 58 or 58A][1] if the [licensed treating clinician][1] is of the opinion that stopping the treatment or treatment provided for in the plan would cause serious suffering to the patient. While arguably one of the reasons for the delay in approving DIOS processing could be a delay in submitting the application for the same, our study shows that DICO applications were sent on average 5.33 days prior to the TTC date. Even though the CQC indicates that it aims to arrange a visit within 5 working days of receiving the medication request and within 2 business days for ECT, 4 our study shows that this time is on average 22 days for medication and 10.5 days for ECT. CTO11 forms were received an average of 21.4 days after the TTC date. Fig. 2 Need for urgent treatment according to §§ 64 B and G. SOAD, second opinion appointed physician. It is recognized that there is an increased demand for legally required second opinions, especially since the introduction of CTO in November 2008 and the requirement that all patients with a CTO should have a treatment plan approved by DICO.
1 This applies regardless of the capacity and consent of the patient concerned. Statistics from England and Wales show that 4107 CTO were carried out during the period 2009-2010. 5 In addition, between their introduction in November 2008 and the end of March 2010, a total of 6241 GMOs were produced, an average of 367 per month. In addition, there were 45,755 hospital detentions during the same period. 5 In 2009-2010, CQC received 8781 DICO applications for drug certification. 5 This represents a total of 6% fewer requests than in the 2008-2009 period. However, the use of emergency treatment powers by drug approval services has increased significantly. In 2004-2005, only 6% of patients had received medication under urgent treatment authority prior to the DICO visit; By 2009-2010, this number had increased to 21% of patients referred for second opinion.
5 Whether this is due to the increase in the number of DICO applications or other difficulties with the CQC – or both – we cannot say. Do you have any conflicts of interest? * Conflict of interest assistance During the 1-year study period, there were 58 cases of Article 62 use in 39 patients (indeed, Article 62 was used more than once in some patients). For section 64B/G, a total of 32 cases were identified in 26 patients.
